BioHealth News Archive
A Year of Historic Action to Combat the Opioid Crisis – The White House
One year ago this week, President Donald J. Trump declared the opioid crisis a public health emergency. Ever since, the Trump Administration has applied…
Read More
Gotham Therapeutics Launches in New York City with $54 Million Series A Financing – BioSpace
Gotham Therapeutics launched in New York with a $54 million Series A financing. The round was co-led by founding investor Versant Ventures, Forbion and…
Read More
How a Pharma Company Applied Machine Learning to Patient Data
The growing availability of real-world data has generated tremendous excitement in health care. By some estimates, health data volumes are increasing by 48% annually,…
Read More
Railing against ‘global freeloading,’ Trump offers plan to lower drug prices – STAT
President Trump on Thursday blasted pharmaceutical companies for having “rigged the system” against American consumers by charging higher prices in the U.S. than they…
Read More
Viewpoint: We need a federal authority to boost ‘tech transfer’ – Washington Business Journal
By Rich Bendis and Brian Darmody While Maryland boasts world-class universities and many private sector firms, the major reason it ranks No. 1 in…
Read More
How Stem Cell Innovation Has Advanced Neuroscience Research – Psychology Today
One of the gating factors in studying the human brain is having the ability to conduct research on actual functioning human brain tissue. As…
Read More
Foundation for the NIH Bestows the Inaugural Trailblazer Prize for Clinician-Scientists to Dr. Michael Fox | FNIH
The Foundation for the National Institutes of Health (FNIH) awarded to Michael Fox, M.D., Ph.D., of Beth Israel Deaconess Medical Center and Harvard Medical…
Read More
University of Maryland School of Medicine to tackle diseases in major new Baltimore research center – Baltimore Sun
The University of Maryland School of Medicine plans to cut the ribbon on the university system’s largest academic building ever Wednesday, a $305 million…
Read More
The FDA Approved a New Flu Treatment In Time for Flu Season – Time
The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment. {iframe}http://time.com/5433403/xofluza-fda-approval/?utm_source=time.com&utm_medium=email&utm_campaign=the-brief&utm_content=2018102512pm&xid=newsletter-brief&eminfo=%7b%22EMAIL%22%3a%22FQSen6Gi%2bvP1kwg88K1Rt6yTrkkPMrpS%22%2c%22BRAND%22%3a%22TD%22%2c%22CONTENT%22%3a%22Newsletter%22%2c%22UID%22%3a%22TD_TBR_187335EB-AD8D-40AA-AE90-07F18992A3F1%22%2c%22SUBID%22%3a%2223900093%22%2c%22JOBID%22%3a%22909835%22%2c%22NEWSLETTER%22%3a%22THE_BRIEF%22%2c%22ZIP%22%3a%22%22%2c%22COUNTRY%22%3a%22USA%22%7d{/iframe}
Read More
10 impact-focused ventures enter Johns Hopkins Social Innovation Lab – Technical.ly Baltimore
Johns Hopkins’ Social Innovation Lab is kicking off a new cohort of early-stage social enterprises addressing challenges around education, health and blight, among others.…
Read More
VERALOX Therapeutics and Frederick Innovative Technology Center, Inc. – Success Story – Baltimore Business Journal
Thrombocytopenia is a big word that can carry big consequences for those struggling with rare blood disorders, especially among those using heparin to treat…
Read More
AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
AstraZeneca, and its global biologics research and development arm MedImmune, today announced a new multi-term agreement with Innate Pharma (Innate), building on an existing…
Read More
MoCo college to target economic development with new ‘RISE Zone’ – Washington Business Journal
Developers qualify if they fill buildings with biotech and cyber firms. {iframe}https://www.bizjournals.com/washington/news/2018/10/23/developers-can-now-get-md-tax-incentives-for.html{/iframe}
Read More
Altimmune CEO Bill Enright to depart – Washington Business Journal
The chief executive will stay in his role, and on the board, until his successor is appointed or early next year, whichever comes first.…
Read More
Doctors are surprisingly bad at reading lab results. It’s putting us all at risk. – The Washington Post
he man was 66 when he came to the hospital with a serious skin infection. He had a fever and low blood pressure, as…
Read More